// App-Quantinova.ai

e15023 : Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA).

Researchers

Presenter

  • Carles Pericay

Principal Investigators

  • Nieves Purificacion Martinez

  • Monica Corral

  • Ismael Macias

  • Olga Donnay

  • Ignacio Juez

  • Beatriz Garcia-Paredes

  • Jose Carlos Mendez

  • Diego Cacho

  • Beatriz Gonzalez Astorga

  • Ana Ruiz

  • Mayte Delgado

  • Nuria Rodriguez

  • Veronica Calderero

  • Elena Mata

  • Juan Antonio Barrera Ramirez

Medical Centers

  • Hospital de Sabadell, Corporacio Sanitaria Parc Tauli, Sabadell, Spain

  • Hospital Universitario A Coruna, A Coruna, Spain

  • Hospital de Alcaniz, Alcaniz, Spain

  • Hospital Parc Tauli Sabadell, Sabadell, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Universitario Fuenlabrada, Fuenlabrada-Madrid, Spain

  • Hospital Clinico San Carlos Madrid, Spain. Spanish Cancer Network (RTICC) (RD06/0020/0021). Instituto Carlos III. Universidad Complutense, IdISCC, Madrid, Spain

  • Centro Oncologico de Galicia, A Coruna, Spain

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Hospital Universitario Puerta Hierro - Majadahonda, Majadahonda-Madrid, Spain

  • Medical Oncology, Hospital Universitario San Cecilio, Granada, Spain

  • Medical Oncology Department. Hospital Universitario La Paz, Madrid, Spain

  • Hospital de Barbastro, Huesca, Spain

  • Medical Oncology, Hospital Reina Sofia, Tudela, Spain

  • Hospital Universitario San Juan de Alicante, Alicante, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Aflibercept

  • FOLFIRI

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved